WALTHAM, Mass. – Apellis Pharmaceuticals, Inc. (NASDAQ:) disclosed on Monday that the European Medicines Agency (EMA) has adjusted the review…
Read More »WALTHAM, Mass. – Apellis Pharmaceuticals, Inc. (NASDAQ:) disclosed on Monday that the European Medicines Agency (EMA) has adjusted the review…
Read More »